Passage BIO(PASG) - 2022 Q4 - Earnings Call Presentation

Fulfilling the Promise of Genetic Medicine for Central Nervous System Disorders March 2023 Nasdaq: PASG © 2023 PassageBio. All rights reserved. Forward-Looking Statement This presentation includes “forward-looking statements” within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned progress of clinical trials and th ...